Most community protocols start cagrilintide at 0.25 mg/week once tirzepatide is established, then step up every 4 weeks to 0.5, 1.0, 1.7, and 2.4 mg/week
The good news is that GLP-1 receptor agonists can be safely used in people with high blood pressure, and evidence suggests they may offer additional benefits for blood pressure control
Currently, there arent many clinical trials looking at psychedelic therapy and sexual function
This is a genuinely difficult question to answer with intellectual honesty
The SDUD is publicly available data provided as part of the Medicaid Drug Rebate Program (MDRP), and provides information on the number of prescriptions, Medicaid spending before rebates, and cost-sharing for rebate-eligible Medicaid outpatient drugs by NDC, quarter, managed care or fee-for-service, and state